Lower exhaled nitric oxide in infants with Cystic Fibrosis compared to healthy controls

Journal of Cystic Fibrosis

Volumn 17, Issue 1, 2018, Pages 105-108

  Korten, Insa ^a,b,c   Liechti, Margot ^a   Singer, Florian ^a,d   Hafen, Gaudenz ^e   Rochat, Isabelle ^e   Anagnostopoulou, Pinelopi ^a   Müller Suter, Dominik ^f   Usemann, Jakob ^a,c   Moeller, Alexander ^d   Frey, Urs ^c   Latzin, Philipp ^a,c   Casaulta, Carmen ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^d UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^e LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^f Children's Hospital Aarau   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; IVACAFTOR; NITRIC OXIDE; BIOLOGICAL MARKER;

ARTICLE; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR DYSFUNCTION; FEMALE; HUMAN; INFANT; MALE; PROTEIN DEFICIENCY; ASYMPTOMATIC DISEASE; BREATH ANALYSIS; COHORT ANALYSIS; EXHALATION; INFLAMMATION; METABOLISM; PROCEDURES; SWITZERLAND;

ASYMPTOMATIC DISEASES; BIOMARKERS; BREATH TESTS; COHORT STUDIES; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EXHALATION; FEMALE; HUMANS; INFANT; INFLAMMATION; MALE; NITRIC OXIDE; SWITZERLAND;

EID: 85023616017     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2017.05.005     Document Type: Article

References (22)

1. Barnes, P.J., Dweik, R.A., Gelb, A.F., Gibson, P.G., George, S.C., Grasemann, H., et al. Exhaled nitric oxide in pulmonary diseases: a comprehensive review. Chest 138 (2010), 682–692.
2. de Winter-de Groot, K.M., van der Ent, C.K., Nitric oxide in cystic fibrosis. J Cyst Fibros 4:Suppl. 2 (2005), 25–29.
3. Robroeks, C.M., Rosias, P.P., van Vliet, D., Jobsis, Q., Yntema, J.B., Brackel, H.J., et al. Biomarkers in exhaled breath condensate indicate presence and severity of cystic fibrosis in children. Pediatr Allergy Immunol 19 (2008), 652–659.
4. Keen, C., Gustafsson, P., Lindblad, A., Wennergren, G., Olin, A.C., Low levels of exhaled nitric oxide are associated with impaired lung function in cystic fibrosis. Pediatr Pulmonol 45 (2010), 241–248.
5. Grasemann, H., Schwiertz, R., Grasemann, C., Vester, U., Racke, K., Ratjen, F., Decreased systemic bioavailability of L-arginine in patients with cystic fibrosis. Respir Res, 7, 2006, 87.
6. Malinovschi, A., Ludviksdottir, D., Tufvesson, E., Rolla, G., Bjermer, L., Alving, K., et al. Application of nitric oxide measurements in clinical conditions beyond asthma. Eur Clin Respir J, 2, 2015, 28517.
7. Chapman, A.L., Morrissey, B.M., Vasu, V.T., Juarez, M.M., Houghton, J.S., Li, C.S., et al. Myeloperoxidase-dependent oxidative metabolism of nitric oxide in the cystic fibrosis airway. J Cyst Fibros 9 (2010), 84–92.
8. Grasemann, H., Al-Saleh, S., Scott, J.A., Shehnaz, D., Mehl, A., Amin, R., et al. Asymmetric dimethylarginine contributes to airway nitric oxide deficiency in patients with cystic fibrosis. Am J Respir Crit Care Med 183 (2011), 1363–1368.
9. Grasemann, H., Shehnaz, D., Enomoto, M., Leadley, M., Belik, J., Ratjen, F., L-ornithine derived polyamines in cystic fibrosis airways. PLoS One, 7, 2012, e46618.
10. Jiao, J., Wang, H., Lou, W., Jin, S., Fan, E., Li, Y., et al. Regulation of ciliary beat frequency by the nitric oxide signaling pathway in mouse nasal and tracheal epithelial cells. Exp Cell Res 317 (2011), 2548–2553.
11. Steagall, W.K., Elmer, H.L., Brady, K.G., Kelley, T.J., Cystic fibrosis transmembrane conductance regulator-dependent regulation of epithelial inducible nitric oxide synthase expression. Am J Respir Cell Mol Biol, 22, 2000, 45.
12. Grasemann, H., Gonska, T., Avolio, J., Klingel, M., Tullis, E., Ratjen, F., Effect of ivacaftor therapy on exhaled nitric oxide in patients with cystic fibrosis. J Cyst Fibros 14 (2015), 727–732.
13. Mika, M., Korten, I., Qi, W., Regamey, N., Frey, U., Casaulta, C., et al. The nasal microbiota in infants with cystic fibrosis in the first year of life: a prospective cohort study. Lancet Respir Med 4 (2016), 627–635.
14. Fuchs, O., Latzin, P., Kuehni, C.E., Frey, U., Cohort profile: the Bern infant lung development cohort. Int J Epidemiol 41 (2012), 366–376.
15. American Thoracic S, European Respiratory S, ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 171 (2005), 912–930.
16. Frey, U., Stocks, J., Sly, P., Bates, J., Specifications for signal processing and data handling used for infant pulmonary function testing. European Respiratory Society/American Thoracic Society. Eur Respir J 16 (2000), 1016–1022.
17. Latzin, P., Kuehni, C.E., Baldwin, D.N., Roiha, H.L., Casaulta, C., Frey, U., Elevated exhaled nitric oxide in newborns of atopic mothers precedes respiratory symptoms. Am J Respir Crit Care Med 174 (2006), 1292–1298.
18. Hall, G.L., Reinmann, B., Wildhaber, J.H., Frey, U., Tidal exhaled nitric oxide in healthy, unsedated newborn infants with prenatal tobacco exposure. J Appl Physiol 92 (2002), 59–66 (1985).
19. Elphick, H.E., Demoncheaux, E.A., Ritson, S., Higenbottam, T.W., Everard, M.L., Exhaled nitric oxide is reduced in infants with cystic fibrosis. Thorax 56 (2001), 151–152.
20. Kotha, K., Szczesniak, R.D., Naren, A.P., Fenchel, M.C., Duan, L.L., McPhail, G.L., et al. Concentration of fractional excretion of nitric oxide (FENO): a potential airway biomarker of restored CFTR function. J Cyst Fibros 14 (2015), 733–740.
21. Gaston, B., Ratjen, F., Vaughan, J.W., Malhotra, N.R., Canady, R.G., Snyder, A.H., et al. Nitrogen redox balance in the cystic fibrosis airway: effects of antipseudomonal therapy. Am J Respir Crit Care Med 165 (2002), 387–390.
22. Szolar, D., Preidler, K., Ranner, G., Braun, H., Kugler, C., Wolf, G., et al. The sphenoid sinus during childhood: establishment of normal developmental standards by MRI. Surg Radiol Anat 16 (1994), 193–198.